# Progress Note 06 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Hubert H. Humphrey (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML022-SYN
- Date: 2026-07-07
- Fictional facility: St. Posthumous Health Center
- Fictional author: Walter Brandvold, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Nine-month follow-up after cystectomy; acid-base on sodium bicarbonate. **S**

## History of present illness

Mr. Humphrey returns three months after his last visit, nine months after his operation and five weeks after his annual wellness visit. He takes sodium bicarbonate twice a day without stomach upset, and the late-afternoon tiredness has gone. He has had no fever, flank pain, or further infection, and no leaks; he changes the appliance every four days. He has had no bone pain, cough, weight loss, change in bowel habit, or rectal bleeding. He works full time and walks 30 minutes most days. **S**

| Element | Detail |
|---|---|
| Acidosis | Tiredness resolved on sodium bicarbonate |
| Stoma | No leaks; skin healthy |
| Recurrence symptoms | None |
| Function | Working full time; walking daily |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy back to normal; weight up; no fever |
| Genitourinary | Negative | Clear urine; no flank pain |
| Gastrointestinal | Negative | No stomach upset on bicarbonate; no change in bowel habit or bleeding |
| Musculoskeletal | Negative | No bone pain |
| Respiratory | Negative | No cough |
| Psychiatric | Negative | Mood good; PHQ-2 score 0 |

6 systems reviewed. **S**

## Current medications

- Sodium bicarbonate 650 mg oral tablet, one tablet by mouth twice daily, for metabolic acidosis after an ileal conduit **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/76 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 78.8 kg; BMI 24.3 kg/m². All vital signs are synthetic.

Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Chloride: 106 mmol/L; Bicarbonate (total CO2): 24 mmol/L; Urea nitrogen: 17 mg/dL; Creatinine: 1.1 mg/dL; eGFR: 74 mL/min/1.73 m²; PHQ-2: 0. All results are synthetic.

## Change since baseline

- Sodium: 139 mmol/L at baseline, 140 mmol/L at this visit **S**
- Potassium: 4.3 mmol/L at baseline, 4.4 mmol/L at this visit **S**
- Chloride: 106 mmol/L at baseline, 106 mmol/L at this visit **S**
- Bicarbonate (total CO2): 22 mmol/L at baseline, 24 mmol/L at this visit **S**
- Urea nitrogen: 18 mg/dL at baseline, 17 mg/dL at this visit **S**
- Creatinine: 1.12 mg/dL at baseline, 1.1 mg/dL at this visit **S**
- eGFR: 73 mL/min/1.73 m² at baseline, 74 mL/min/1.73 m² at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Soft and non-tender; no masses; no hernia |
| Stoma | Pink and moist; peristomal skin healthy |
| Lymph nodes | No inguinal or supraclavicular nodes |
| Extremities | No edema |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hyperchloremic metabolic acidosis from the ileal conduit, corrected** (E87.22). Bicarbonate 24 mmol/L and chloride 106 mmol/L on sodium bicarbonate; creatinine 1.10 mg/dL, stable. **S**
   - Continue sodium bicarbonate 650 mg twice daily.
   - Chemistry at one year after surgery, then yearly if stable.
2. **Bladder cancer after radical cystoprostatectomy, pT2a N0, no evidence of disease** (Z85.51). No symptoms or signs of recurrence nine months after surgery. **S**
   - CT of the chest, abdomen, and pelvis with a urographic phase in three months, at one year after surgery.
   - Written survivorship care plan given today: the surveillance schedule, symptoms to report (blood from the stoma, flank or bone pain, weight loss, a bulge by the stoma), and who to call.
   - Urology review with the CT.
3. **Ileal conduit urostomy** (Z93.6). Stoma healthy; no hernia. **S**
   - Continue the current appliance; stoma nurse review yearly or for any problem.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Chemistry with creatinine, chloride, and bicarbonate | Every 3 to 6 months in the first year after diversion, then yearly | Completed today | Creatinine 1.10 mg/dL, eGFR 74; chloride 106, bicarbonate 24 mmol/L on treatment |
| Laboratory | Vitamin B12 | Yearly from two to three years after an ileal diversion | Up to date | Baseline normal six months ago |
| Imaging | CT of the chest, abdomen, and pelvis (with urographic phase) | Every 6 to 12 months for 2 to 3 years after cystectomy, then yearly | Due | At one year after surgery, in three months; the urographic phase covers the upper tracts |
| Imaging | Upper-tract imaging (renal ultrasound or CT urography) | Every 6 months to year 3, then yearly | Up to date | Renal ultrasound three months ago without hydronephrosis; next with the CT |
| Examination | Stoma and peristomal skin | Every visit | Completed today | Healthy |
| Examination | Parastomal and incisional hernia | Every visit | Completed today | None |
| Medication safety | Sodium bicarbonate: tolerance and sodium load | Every visit on alkali therapy | Completed today | No bloating; blood pressure 128/76 mm Hg; no edema |
| Survey | Distress and depression screen (PHQ-2) | Every visit | Completed today | PHQ-2 score 0 |
| Laboratory | Routine urine culture of conduit urine | Only for fever, flank pain, or other signs of infection | Not indicated | Bacteria are expected in conduit urine; no symptoms today |
| Laboratory | Urethral wash cytology | Periodically if the urethra is retained and at high risk | Not indicated | Urethral margin negative and no prostatic urethral involvement |
| Self-management | Survivorship care plan, fluid intake, and activity | After treatment; fluids and activity every visit | Completed today | Written plan given; about 2 liters of fluid a day; walking 30 minutes most days |

## Goal progress

- Leak-free urostomy appliance with healthy peristomal skin. Outcome by 2026-04-07: Appliance refitted with a convex wafer at the consultation; no leaks in the two months after the refit and skin healed. **S**
- Stable kidney function (creatinine within 0.3 mg/dL of the post-operative baseline) and bicarbonate 22 mmol/L or more. Outcome by 2026-07-07: Creatinine 1.10 mg/dL; bicarbonate 24 mmol/L on sodium bicarbonate. **S**
- Regain stamina after surgery: walk 30 minutes a day and regain weight. Outcome by 2026-04-07: Walking 30 minutes most days; weight up 1.1 kg since the first visit. **S**
- Written survivorship surveillance schedule in place, shared between urology and primary care. Outcome by 2026-07-07: Schedule given; CT due at one year after surgery. **S**

## Guideline basis

- Holzbeierlein J, et al. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024). J Urol 2024;212(1):3-10 (2024), American Urological Association, American Society of Clinical Oncology, and Society of Urologic Oncology
- NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer (2026), National Comprehensive Cancer Network
- CMID: Clinical Monitoring Intelligence Database, urologic cancer monograph (2026), Aether Forge

## Follow-up

- CT and urology review in three months, at one year after surgery. Primary care at the same time with chemistry. **S**

